The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Thu, May 19, 2022 | 18:08
Health & Science
Korea aiming to release antibody treatment drug for COVID-19 in 2021
Posted : 2020-04-14 13:56
Updated : 2020-04-14 18:01
Print Preview
Font Size Up
Font Size Down
Yoon Tae-ho. Yonhap
Yoon Tae-ho. Yonhap

South Korea seeks to carry out clinical tests on antibody-based treatment for the novel coronavirus within the year, with the aim of releasing a drug in 2021, a senior official said Tuesday.

The country is mapping out a governmentwide support system to find a treatment method and vaccine to combat COVID-19.

"Coming up with a drug and vaccine is the only way to deal with the pandemic," said Yoon Tae-ho, a government official in charge of the quarantine.

The large amount of blood samples collected from people infected with the virus in the country will help actual clinical tests on antibody drugs take place before the end of 2020.

Also a process of using blood plasma taken from recovered COVID-19 patients may be developed in the next two to three months, as joint work is under way with local biotech companies, according to the official.

If meaningful progress is made, actual drugs could come out next year, with a vaccine, to inoculate people from infections, to be made available in late 2021 or 2022, he said.

The country has streamlined rules to better secure blood samples from patients and has eased unnecessary restrictions that can hold back various testing.

The country has so far reported over 10,500 virus cases since its first outbreak in late January. (Yonhap)


 
  • People in North Korea trapped in famine and pandemic [PHOTOS]
  • Kim says Chinese permanent residents should be stripped of right to vote in Korea
  • Anti-LGBTQ sentiment widespread in Korea: survey
  • South Korea to join US-led Indo-Pacific economic initiative
  • Protecting Korea's semiconductor leadership
  • CJ, Ottogi uneasy about Harim's tactics to sell new cooked rice
  • [INTERVIEW] Yoon's efforts to bolster Korea-US alliance will inevitably disturb China
  • North Korea asks China, Russia for help amid COVID crisis: reports
  • Luna debacle casts ripple effect over Korean stocks
  • Fear of deadliest famine in 1990s haunts North Korea amid national lockdown
  • Le Sserafim member Kim Ga-ram's bullying allegations resurface Le Sserafim member Kim Ga-ram's bullying allegations resurface
  • PSY's first boy group TNX makes much-anticipated debut with EP 'Way Up' PSY's first boy group TNX makes much-anticipated debut with EP 'Way Up'
  • Girls' Generation to make comeback in August after five years Girls' Generation to make comeback in August after five years
  • Musical 'Beethoven' to hit stage next year Musical 'Beethoven' to hit stage next year
  • 'Doctor Strange 2' tops 5 million admissions 'Doctor Strange 2' tops 5 million admissions
DARKROOM
  • People in North Korea trapped in famine and pandemic [PHOTOS]

    People in North Korea trapped in famine and pandemic [PHOTOS]

  • 2022 Pulitzer Prize: Bearing witness to history

    2022 Pulitzer Prize: Bearing witness to history

  • Worsening drought puts millions at risk

    Worsening drought puts millions at risk

  • Our children deserve the best

    Our children deserve the best

  • End of mask mandates

    End of mask mandates

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group